Modality of chronic renal replacement therapy and survival-a complete cohort from Finland, 2000-2009

被引:12
作者
Haapio, Mikko [1 ]
Helve, Jaakko [2 ]
Kyllonen, Lauri [3 ,4 ]
Gronhagen-Riska, Carola [2 ,5 ]
Finne, Patrik [1 ,5 ]
机构
[1] Univ Helsinki, Cent Hosp, Div Nephrol, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
[3] Finnish Kidney Transplant Registry, Dept Surg, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
[5] Finnish Registry Kidney Dis, Helsinki, Finland
关键词
dialysis modality; haemodialysis; peritoneal dialysis; renal replacement therapy; survival; AMBULATORY PERITONEAL-DIALYSIS; ADJUSTED MORTALITY-RATES; CONGESTIVE-HEART-FAILURE; PATIENT SURVIVAL; SIMILAR OUTCOMES; ESRD PATIENTS; HEMODIALYSIS; DISEASE; EUROPE; RISK;
D O I
10.1093/ndt/gft326
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Studies on dialysis modality and survival have shown conflicting results, mostly due to insufficient and varying control of confounding factors. Using comprehensive data on a well-defined patient cohort, we therefore investigated the association of dialysis modality with survival on chronic renal replacement therapy (RRT) and whether this association varies between subgroups of patients. Survival analyses included all adult patients entering chronic RRT in Finland between 2000 and 2009 and used information obtained from the Finnish Registry for Kidney Diseases and the Finnish Kidney Transplant Registry. In our primary intention-to-treat (ITT) analysis, we calculated relative risk of death according to dialysis modality on Day 91 from RRT start, comparing peritoneal dialysis (PD) to haemodialysis (HD). Relative risks were adjusted for putative confounders. Interactions between treatment groups and other variables were estimated. Of the total 4463 patients, 42 died during the 10 years of follow-up. Median survival time was 5.2 years. In unadjusted ITT analysis, relative risk of death of PD patients was 0.65 (95 CI 0.580.73, P 0.001) compared with HD patients. With adjustment for 26 variables, the corresponding relative risk of death was 1.07 (95 CI 0.941.22, P 0.33). When censoring at time of kidney transplantation, the result was similar with a relative risk of death of 1.09 (95 CI 0.951.25, P 0.24) on PD compared with HD. PD is associated with several factors generally related to good prognosis. After comprehensive adjustment for putative confounding factors with the ITT analysis approach, we found no significant difference in survival between PD and HD patients.
引用
收藏
页码:3072 / 3081
页数:10
相关论文
共 50 条
  • [21] Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden
    Eriksson, Jonas K.
    Neovius, Martin
    Jacobson, Stefan H.
    Elinder, Carl-Gustaf
    Hylander, Britta
    BMJ OPEN, 2016, 6 (10):
  • [22] Modality transition on renal replacement therapy and quality of life of patients: a 10-year follow-up cohort study
    Daniela Cristina Sampaio de Brito
    Elaine Leandro Machado
    Ilka Afonso Reis
    Daniela Pena Moreira
    Thiago Henrique Mascarenhas Nébias
    Mariângela Leal Cherchiglia
    Quality of Life Research, 2019, 28 : 1485 - 1495
  • [23] Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data
    Fotheringham, James
    Jacques, Richard M.
    Fogarty, Damian
    Tomson, Charles R. V.
    El Nahas, Meguid
    Campbell, Michael J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) : 422 - 430
  • [24] Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry
    Spithoven, Edwin M.
    Kramer, Anneke
    Meijer, Esther
    Orskov, Bjarne
    Wanner, Christoph
    Abad, Jose M.
    Areste, Nuria
    Alonso de la Torre, Ramon
    Caskey, Fergus
    Couchoud, Cecile
    Finne, Patrik
    Heaf, James
    Hoitsma, Andries
    de Meester, Johan
    Pascual, Julio
    Postorino, Maurizio
    Ravani, Pietro
    Zurriaga, Oscar
    Jager, Kitty J.
    Gansevoort, Ron T.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 15 - 25
  • [25] Choice of renal replacement therapy modality in intensive care units: Data from a Japanese Nationwide Administrative Claim Database
    Iwagami, Masao
    Yasunaga, Hideo
    Noiri, Eisei
    Horiguchi, Hiromasa
    Fushimi, Kiyohide
    Matsubara, Takehiro
    Yahagi, Naoki
    Nangaku, Masaomi
    Doi, Kent
    JOURNAL OF CRITICAL CARE, 2015, 30 (02) : 381 - 385
  • [26] Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie
    Bechade, Clemence
    Dejardin, Olivier
    Bara, Simona
    Bouvier, Veronique
    Guizard, Anne-Valerie
    De Mil, Remy
    Troussard, Xavier
    Lobbedez, Thierry
    Launoy, Guy
    JOURNAL OF NEPHROLOGY, 2018, 31 (01) : 111 - 118
  • [27] Renal replacement therapy for diabetic end-stage renal disease:: Data from 10 registries in Europe (1991-2000)
    Van Dijk, PCW
    Jager, KJ
    Stengel, B
    Grönhagen-Riska, C
    Feest, TG
    Briggs, JD
    KIDNEY INTERNATIONAL, 2005, 67 (04) : 1489 - 1499
  • [28] Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy A cohort study in Taiwan
    Cheng, Kao-Chi
    Liao, Kuan-Fu
    Lin, Cheng-Li
    Liu, Chiu-Shong
    Lai, Shih-Wei
    MEDICINE, 2018, 97 (39)
  • [29] Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
    Chen, Yi-Chun
    Chen, Yen-Chun
    Chiou, Wen-Yen
    Yu, Ben-Hui
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [30] Advanced chronic kidney disease in elderly under renal replacement therapy and conservative treatment. Comparative Survival and symptoms study
    Rubio Rubio, Maria Victoria
    Lou Arnal, Luis Miguel
    Gimeno Orna, Jose Antonio
    Hernandez Machin, Pilar
    Martinez Pagan, Esperanza
    Lamban Ibor, Elena
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2021, 41 (03): : 173 - 183